全性TYK2特定抑制剂的三重作用抑制机制
Jimin Wang1, Victor S Batista2, Christopher G Bunick1,3,4
1Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA.
bioRxiv : the preprint server for biology
|October 24, 2023
概括
德乌克拉维西替尼通过与其伪激酶域结合,选择性地抑制TYK2 (Janus激酶),影响多个激酶状态并限制活性. 这提供了对其治疗潜力的机制性理解.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 德乌克拉维西提尼布是一种选择性TYK2抑制剂,向JAK-STAT通路.
- 对于deucravacitinib的选择性和全抑制的结构基础尚不清楚.
- TYK2调解了干扰素诱导的快速基因表达.
研究的目的:
- 调查deucravacitinib在TYK2.2上的抑制机制.
- 阐明deucravacitinib选择性和全抑制的结构基础.
- 了解TYK2在干扰素信号传递中的作用.
主要方法:
- 对TYK2域 (FERM-SH2和JH2-JH1) 的可用晶体结构的分析.
- 对deucravacitinib与TYK2.2相互作用的计算分析.
- 在自身抑制和激活酶状态之间研究了抑制.
主要成果:
- 德乌克拉维西替尼在三个不同的状态中与TYK2结合:自抑制状态和两个激活状态.
- 与伪激酶域的结合限制了激酶活动的基本动态.
- 德乌克拉维西丁尼作为一种竞争性ATP抑制剂,并且在固态上阻碍活性状态的形成.
结论:
- 德乌克拉维西替尼的全抑制机制涉及与伪激酶域结合.
- 该药物通过动态限制和固态阻碍来阻止TYK2的激活.
- 这为deucravacitinib在JAK-STAT通路调节中的有效性提供了机制基础.
相关概念视频
Allosteric Regulation
58.1K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.1K
Receptor Tyrosine Kinases
13.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Enzyme-linked Receptors
78.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K


